ALPINE IMMUNE SCIENCES, INC.
Total Trades
21
Buys
3
Sells
11
Largest Trade
$1M+
Insiders
8
Institutional Funds
3
Inst. Value
$500K+
Activist Filings
38
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Topper James N | Director | SELL | $1K–$15K | 19 | $64.57 | Apr 29, 2024 |
| Rickey James Paul | See Remarks | SELL | $1M+ | 118K | $23.31 | Jan 30, 2024 |
| Rickey James Paul | See Remarks | EXERCISE | $500K+ | 118K | $8.30 | Jan 30, 2024 |
| GOLD MITCHELL | Executive Chairman… | EXERCISE | $500K+ | 75K | $12.58 | Dec 30, 2023 |
| GOLD MITCHELL | Executive Chairman… | SELL | $15K–$50K | 1K | $20.04 | Dec 30, 2023 |
| Thompson Peter A. | Director | SELL | $1M+ | 1.5M | $18.54 | Dec 29, 2023 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 1.5M | $18.54 | Dec 29, 2023 |
| GOLD MITCHELL | Executive Chairman… | SELL | $1M+ | 92K | $20.25 | Dec 28, 2023 |
| GOLD MITCHELL | Executive Chairman… | EXERCISE | $50K–$100K | 92K | $0.56 | Dec 28, 2023 |
| Rickey James Paul | See Remarks | SELL | $100K–$500K | 15K | $19.21 | Dec 22, 2023 |
| Rickey James Paul | See Remarks | EXERCISE | $50K–$100K | 15K | $5.02 | Dec 22, 2023 |
| GOLD MITCHELL | Executive Chairman… | EXERCISE | $1K–$15K | 2K | $0.45 | Dec 22, 2023 |
| GOLD MITCHELL | Executive Chairman… | SELL | $15K–$50K | 2K | $20.01 | Dec 22, 2023 |
| Rickey James Paul | See Remarks | SELL | $1K–$15K | 700 | $16.00 | Dec 1, 2023 |
| Rickey James Paul | See Remarks | EXERCISE | $1K–$15K | 700 | $3.23 | Dec 1, 2023 |
| Decheng Capital Global Healthcare Fund (Master), LP | 10% Owner | BUY | $1M+ | 375K | $12.50 | Nov 14, 2023 |
| Cui Xiangmin | Director | BUY | $1M+ | 375K | $12.50 | Nov 14, 2023 |
| Rickey James Paul | See Remarks | EXERCISE | $15K–$50K | 11K | $3.23 | Nov 8, 2023 |
| Rickey James Paul | See Remarks | SELL | $100K–$500K | 18K | $16.03 | Nov 8, 2023 |
| Frazier Life Sciences VIII, L.P. | 10% Owner | BUY | $500K+ | 113K | $7.10 | Feb 15, 2022 |
| Rickey James Paul | Senior VP and CFO | SELL | $100K–$500K | 17K | $13.92 | Jan 4, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2024 · 3 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 18K | $500K+ | SH |
| Legal & General Group Plc | 4K | $100K–$500K | SH |
| DEUTSCHE BANK AG\ | 960 | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
Decheng Capital China Life Sciences USD Fund III, L.P.
SC 13D/A · May 21, 2024
0.0%
0 shares
Frazier Life Sciences VIII, L.P. 2.
SC 13D/A · May 21, 2024
0 shares
Decheng Capital China Life Sciences USD Fund III, L.P.
SC 13D/A · Apr 30, 2024
10.0%
6.6M shares
Frazier Life Sciences VIII, L.P. 2.
SC 13D/A · Apr 29, 2024
4.3%
2.8M shares
SC 13G/A · Mar 7, 2024
4.6%
3.0M shares
SC 13G/A · Feb 14, 2024
10.0%
5.9M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
6.4%
3.7M shares
ALPINE IMMUNE SCIENCES, INC. (Subject)
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2024
4.4%
2.5M shares
SC 13G/A · Feb 14, 2024
6.6%
3.8M shares
SC 13G · Feb 2, 2024
5.3%
3.1M shares
SC 13D/A · Dec 29, 2023
4.6%
2.7M shares
Frazier Life Sciences VIII, L.P.
SC 13D/A · Nov 22, 2023
4.7%
2.8M shares
Decheng Capital China Life Sciences USD Fund III, L.P.
SC 13D/A · Nov 14, 2023
11.1%
6.6M shares
SC 13D/A · Nov 14, 2023
4.6%
2.7M shares
SC 13D/A · Nov 13, 2023
7.3%
4.2M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G · Oct 23, 2023
5.8%
2.9M shares
SC 13G/A · Feb 14, 2023
7.9%
3.6M shares
SC 13G/A · Feb 14, 2023
9.6%
4.4M shares
SC 13G/A · Feb 14, 2023
6.8%
3.1M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2023
4.0%
1.9M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 13, 2023
1.6%
725K shares
SC 13G/A · Feb 13, 2023
5.2%
2.4M shares
SC 13G · Oct 3, 2022
9.9%
4.4M shares
SC 13G · Sep 30, 2022
7.8%
3.4M shares
SC 13D/A · Sep 27, 2022
6.1%
2.7M shares
SC 13D/A · Sep 27, 2022
9.3%
4.1M shares
Decheng Capital China Life Sciences USD Fund III, L.P.
SC 13D/A · Sep 27, 2022
14.6%
6.6M shares
SC 13G · Apr 22, 2022
5.1%
1.5M shares
Frazier Life Sciences VIII, L.P.
SC 13D/A · Feb 15, 2022
5.5%
1.6M shares
SC 13G/A · Feb 14, 2022
8.2%
2.4M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2022
2.9%
847K shares
Decheng Capital Management III (Cayman), LLC
SC 13G · Feb 14, 2022
16.1%
4.7M shares
Avidity Partners Management LP
SC 13G/A · Feb 12, 2022
7.3%
2.2M shares